SIMILASAN Rhume liquide glob 15 g
7680506720430
CH-50672
20.01.1.
1 / 2
google
Details
- Product number
- 5067201
- CPT
- -
- Packaging group
- 15
- Unit
- g
- Composition
- allium cepa (HAB) D4 8.500 mg, allium cepa (HAB) D10 1.000 mg, allium cepa (HAB) D15 0.500 mg, calcii carbonas, xylitolum, ad globulos pro 1 g corresp. 70-90 granula homoeopathica imbuta.
Articles (1)
Similasan Fliess-Schnupfen, Globuli
Globuli
15
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
8.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
1.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
0.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Similasan AG
8916 Jonen
Authorization information
- Swissmedic authorization number
- 50672
- Drug name
- Similasan Fliess-Schnupfen, Globuli
- Galenic form
- GLO
- Authorization status
- Z
- Dispensation category
- D
- First authorization
- 17/10/1991
- Authorization expiration date
- 31/12/9999
- IT number
- 20.01.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SIMILASAN Rhume liquide glob 15 g
- Description (DE)
- SIMILASAN Fliess-Schnupfen Glob 15 g
- Market launch
- 17/10/1991
- Narcotic (BTM)
- No